MTOR and metabolic dysfunction-associated steatotic liver disease: Furthermore, the mammalian target of rapamycin (mTOR), an atypical serine/threonine protein kinase and a member of the phosphatidylinositol kinase-related kinase (PIKK) family, plays an important role in NAFLD as Table 1 shows.